This is an old revision of this page, as edited by حسن علي البط (talk | contribs) at 08:49, 27 August 2010 (Removed Category:Nootropics (using HotCat)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 08:49, 27 August 2010 by حسن علي البط (talk | contribs) (Removed Category:Nootropics (using HotCat))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
 | |
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.111.445  |
| Chemical and physical data | |
| Formula | C8H14N2O2 |
| Molar mass | 170.209 g/mol g·mol |
| 3D model (JSmol) | |
SMILES
| |
Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.
See also
| Racetams | |
|---|---|
| Racetams |
|
| Phenylpiracetams |
|
| Racetam-like |
|
 | This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |